loadpatents
Patent applications and USPTO patent grants for Mayer; John P..The latest application filed is for "aqueously soluble & chemically stable glucagon peptides".
Patent | Date |
---|---|
Aqueously soluble and chemically stable glucagon peptides Grant 10,683,334 - Dimarchi , et al. | 2020-06-16 |
Lipidated amide-based insulin prodrugs Grant 10,385,107 - Dimarchi , et al. A | 2019-08-20 |
Aqueously Soluble & Chemically Stable Glucagon Peptides App 20190218268 - DIMARCHI; Richard D. ;   et al. | 2019-07-18 |
Incretin-insulin conjugates Grant 10,232,020 - Dimarchi , et al. | 2019-03-19 |
Incretin-insulin Conjugates App 20170281788 - DIMARCHI; Richard D. ;   et al. | 2017-10-05 |
Lipidated Amide-based Insulin Prodrugs App 20170283479 - DIMARCHI; Richard D. ;   et al. | 2017-10-05 |
Melanocortin receptor 4 (mc4) agonists and their uses App 20070105759 - Flora; David Benjamin ;   et al. | 2007-05-10 |
Uses of melanocortin-3 receptor (mc3r) agonist peptides App 20060293223 - Gadski; Robert Alan ;   et al. | 2006-12-28 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.